公开(公告)号：US20080039514A1

公开(公告)日：2008-02-14

申请号：US11662808

申请日：2005-09-12

申请人： James Dropinski ,  Guo Shi ,  Yong Zhang

发明人： James Dropinski ,  Guo Shi ,  Yong Zhang

IPC分类号： A61K31/42 ,  A61P3/00 ,  C07D261/20

CPC分类号： C07D261/20 ,  C07D413/12

摘要： A class of compounds having Formula I and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of developing conditions and sequelae that are associated with these diseases, such as atherosclerosis.

摘要翻译： 一类具有式I的化合物及其药学上可接受的盐可用作治疗性化合物，特别是用于治疗高脂血症，高胆固醇血症，血脂异常和其它脂质疾病，以及延迟发展或降低发展疾病和后遗症的风险， 与这些疾病有关，如动脉粥样硬化。

公开(公告)号：US20070173434A1

公开(公告)日：2007-07-26

申请号：US10586976

申请日：2005-01-18

申请人： Guo Shi ,  Peter Meinke ,  James Dropinski ,  Yong Zhang

发明人： Guo Shi ,  Peter Meinke ,  James Dropinski ,  Yong Zhang

IPC分类号： A61K31/427 ,  A61K31/421 ,  A61K38/28 ,  C07D263/04 ,  C07D277/04

CPC分类号： C07D263/44 ,  A61K38/26 ,  A61K38/28 ,  C07D263/64 ,  C07D277/34 ,  A61K2300/00

摘要： Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones of formula (I) are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

摘要翻译： 式（I）的苯氧基苯基和苯氧基苄基恶唑烷-2,4-二酮和噻唑烷-2,4-二酮是PPARγ的激动剂或部分激动剂，可用于治疗和控制II型糖尿病症状的高血糖，如 以及通常与2型糖尿病相关的血脂异常，高脂血症，高胆固醇血症，高甘油三酯血症和肥胖。

公开(公告)号：US20050228044A1

公开(公告)日：2005-10-13

申请号：US10522259

申请日：2003-07-25

申请人： Guo Shi ,  Yong Zhang

发明人： Guo Shi ,  Yong Zhang

IPC分类号： A61K31/00 ,  A61K45/06 ,  C07D307/85 ,  C07D307/93 ,  C07D413/06 ,  A61K31/343

CPC分类号： C07D413/06 ,  A61K31/00 ,  A61K45/06 ,  C07D307/85 ,  C07D307/93 ,  A61K2300/00

摘要： A class of benzodihydrofuran compounds having the structure of formula (I) below and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of conditions and sequelae that are associated with these diseases, such as atherosclerosis.

摘要翻译： 一类具有下式（I）结构的苯并二氢呋喃化合物及其药学上可接受的盐可用作治疗性化合物，特别是用于治疗高脂血症，高胆固醇血症，血脂异常和其它脂质疾病，并且延迟开始或减少 与这些疾病相关的病症和后遗症的风险，如动脉粥样硬化。

公开(公告)号：USD932680S1

公开(公告)日：2021-10-05

申请号：US29762482

申请日：2020-12-16

申请人： Yong Zhang

设计人： Yong Zhang

公开(公告)号：US11092877B2

公开(公告)日：2021-08-17

申请号：US16921973

申请日：2020-07-07

申请人： SHENZHEN FOTOTECH PHOTOGRAPHIC EQUIPMENT CO., LTD ,  Yong Zhang

发明人： Chai Yee Ho ,  Yong Zhang

IPC分类号： G03B15/06 ,  F21V7/18 ,  G03B17/56 ,  F21V3/02 ,  F21V29/10 ,  F21V21/092

摘要： Disclosed is an inflatable soft box, which belongs to the technical field of photography and film and television. The present application compromises a flexible case. An inflatable nozzle is provided on the flexible case, and the inflatable nozzle is used to inflate or deflate the flexible case. A soft lamp is provided on the flexible case, and the soft lamp is used to illuminate the flexible case. The structure of the inflatable soft box of the present application is simple. By providing an inflation nozzle on the flexible case, the flexible case is inflated by the inflation nozzle when in use, and the flexible case is inflated; when not in use, the flexible case is deflated by the inflation nozzle, making it easy to carry or move, and convenient for users to use.

公开(公告)号：US20170228361A1

公开(公告)日：2017-08-10

申请号：US15429094

申请日：2017-02-09

申请人： Yong Zhang ,  Ning Liu

发明人： Yong Zhang ,  Ning Liu

IPC分类号： G06F17/27 ,  G06F17/30

摘要： A computer system for parsing bulk message information into intelligent question retrieval models receives text-based data associated with a particular user. The system encodes the word into a context-dependent vector, wherein the context-dependent vector indicates the meaning of the word across a semantic space. The system also identifies within a context-independent database a context-independent vector that is associated with the word. Further, the system generates an objective output by combining the context-dependent vector and the context-independent vector. Further still, the system generates a sentence encoding representation by processing at least a portion of the text-based data through a high-level feature embedded convolutional semantic model to generate numerical representations of questions and answers within the text-based dataset. The sentence encoding representation is generated at least in part based upon the objective output.

公开(公告)号：US09626586B2

公开(公告)日：2017-04-18

申请号：US14320092

申请日：2014-06-30

申请人： Yong Zhang ,  Ravishankar Iyer ,  Rameshkumar G. Illikkal ,  Donald K. Newell ,  Jianping Zhou

发明人： Yong Zhang ,  Ravishankar Iyer ,  Rameshkumar G. Illikkal ,  Donald K. Newell ,  Jianping Zhou

IPC分类号： G06K9/00 ,  G06K9/48 ,  G06K9/46

CPC分类号： G06K9/481 ,  G06K9/00973 ,  G06K9/4671 ,  G06K2009/485

摘要： Methods and systems of recognizing images may include an apparatus having a hardware module with logic to, for a plurality of vectors in an image, determine a first intermediate computation based on even pixels of an image vector, and determine a second intermediate computation based on odd pixels of an image vector. The logic can also combine the first and second intermediate computations into a Hessian matrix computation.

公开(公告)号：US09601579B2

公开(公告)日：2017-03-21

申请号：US14786029

申请日：2014-05-27

申请人： Yong Zhang ,  Raphael Tsu ,  Naili Yue

发明人： Yong Zhang ,  Raphael Tsu ,  Naili Yue

IPC分类号： H01L21/20 ,  H01L29/16 ,  H01L21/02 ,  H01L29/165

CPC分类号： H01L29/16 ,  H01L21/0242 ,  H01L21/02444 ,  H01L21/02488 ,  H01L21/02502 ,  H01L21/02532 ,  H01L21/0259 ,  H01L21/02598 ,  H01L21/0262 ,  H01L21/02631 ,  H01L21/02658 ,  H01L29/1606 ,  H01L29/165

摘要： Graphene is used as an interfacial layer to grow Si and other semiconductors or crystalline materials including two-dimensional Si and other structures on any foreign substrate that can withstand the growth temperature without the limitation matching condition typically required for epitaxial growth.

公开(公告)号：US20160304537A1

公开(公告)日：2016-10-20

申请号：US15103148

申请日：2014-12-05

申请人： Xiaoqing HAN ,  Alan WHITEHEAD ,  Subharekha RAGHAVAN ,  Timothy A. CERNAK ,  Spencer DREHER ,  Jonathan GROEPER ,  Jian GUO ,  Yong ZHANG ,  MERCK SHARP & DOHME CORP.

发明人： Xiaoqing Han ,  Alan Whitehead ,  Subharekha Raghavan ,  Timothy A. Cernak ,  Spencer Dreher ,  Jonathan Groeper ,  Jian Guo ,  Yong Zhang

IPC分类号： C07D519/00 ,  A61K45/06 ,  A61K31/519

CPC分类号： C07D519/00 ,  A61K31/519 ,  A61K31/52 ,  A61K45/06 ,  C07B2200/05 ,  A61K2300/00

摘要： A compound of Formula I or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula I or a pharmaceutically acceptable salt thereof.

公开(公告)号：US20160304536A1

公开(公告)日：2016-10-20

申请号：US15103140

申请日：2014-12-05

申请人： Xiaoqing HAN ,  Alan WHITEHEAD ,  Subharekha RAGHAVAN ,  Jonathan GROEPER ,  Jian GUO ,  Yong ZHANG ,  MERCK SHARP & DOHME CORP.

发明人： Xiaoqing Han ,  Alan Whitehead ,  Subharekha Raghavan ,  Jonathan Groeper ,  Jian Guo ,  Yong Zhang

IPC分类号： C07D519/00 ,  A61K31/519 ,  A61K45/06

CPC分类号： C07D519/00 ,  A61K31/519 ,  A61K31/52 ,  A61K45/06 ,  A61K2300/00

摘要： A compound of Formula I or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula I or a pharmaceutically acceptable salt thereof.

摘要翻译： 式I化合物或其药学上可接受的盐能够调节身体产生环鸟苷酸（“cGMP”），并且通常适用于治疗和预防与受干扰的cGMP平衡有关的疾病。 本发明还涉及用于制备式I化合物或其药学上可接受的盐的方法，用于治疗和预防上述疾病和用于制备用于该目的的药物以及包含式I化合物的药物制剂 或其药学上可接受的盐。